Clinical Trials Directory

Trials / Completed

CompletedNCT02373020

Enteropathogenic Escherichia Coli (EPEC): Does it Have a Role in Colorectal Tumourigenesis?

ROLE OF E COLI IN Colorectal Tumourigenesis

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Despite the characterization of many aetiologic genetic changes. The specific causative factors in the development of sporadic colorectal cancer remain unclear. This study was performed to detect the possible role of Enteropathogenic Escherichia coli (EPEC) in developing colorectal carcinoma.

Detailed description

Fresh biopsy specimens have been obtained from the colonic mucosa overlying the colorectal cancer as well as from the colon of the healthy controls. Culture, genotyping and virulence of EPEC were done using (nutrient broth culture, and PCR). Strains biochemically identified as E. coli were selected from the surface of a MacConkey's plate and were serogrouped by slide agglutination tests

Conditions

Interventions

TypeNameDescription
OTHERcolonoscopic biopsies

Timeline

Start date
2011-01-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2015-02-26
Last updated
2015-04-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02373020. Inclusion in this directory is not an endorsement.